Skip to navigation Skip to main content Skip to footer

Approved Research

Study for pharmacogenomic mapping for histology-specific cancer susceptibility

Principal Investigator: Dr Sungji Moon
Approved Research ID: 97642
Approval date: March 29th 2023

Lay summary

We are going to find genetic risks for specific cancer associated with medications people commonly get. There have been lots of studies regarding genetic susceptibility to cancer risk. Commonly prescribed medications, including non-steroidal anti-inflammatory drugs, statin, aspirin, etc., can also affect cancer incidence. However, the effect of their interaction on cancer risk is unknown yet, and elucidation of their link could keep people susceptible to unexpected specific cancer risks from getting the medication. This project will take up to a 3-year. In respect of public health, this study can identify the high-risk population for specific cancer associated with commonly prescribed medication.